"group of disorders characterized by the excessive production of porphyrins or their precursors that arises from abnormalities in the regulation of the porphyrin-heme pathway; acquired porphyrias, which are due to inhibition of enzymes in the metabolic pathway by a drug, toxin or abnormal metabolite, are more common than those which are inherited."
The following information has been extracted from US Food and Drug Administration databases.
It shows drugs which may be used to treat this condition, and those drugs whose use may be dangerous with this condition.
This is informational only. You must consult a physician for your particular case. You may click on a listed drug for further information.
The following medications may be indicated for this condition